Heavyweights By Shraddha Chakradhar At the top of her field, a Covid-19 researcher fights back against a different kind of virus: sexism and power imbalances in science
Heavyweights By Lev Facher How Joe Grogan, a former pharma lobbyist, upended Trump’s drug pricing agenda
Heavyweights By Sharon Begley ‘I really don’t know what happened to Jim’: Friends ask where James Watson’s odious attitudes about race came from
Exclusive By Sharon Begley Out of prison, the ‘father of gene therapy’ faces a harsh reality: a tarnished legacy and an ankle monitor
Heavyweights By Eric Boodman It’s not ‘all in your head’: When other doctors give up on patients, a boundary-breaking neurologist treats them
Heavyweights By Usha Lee McFarling Near the campus cow pasture, a scientist works to grow human organs — in pigs
Heavyweights By Meghana Keshavan Did he really just tweet that? Dr. Vinay Prasad takes on Big Pharma, Big Medicine, and his own colleagues — with glee
Heavyweights By Lev Facher Eric Lander is brilliant, connected, and controversial. Now Joe Biden wants him to ‘reinvigorate’ American science
Heavyweights By Nicholas Florko A former FDA chief, brimming with experience but lacking in niceties, surprises Washington by winning Biden’s trust
Heavyweights By Usha Lee McFarling A ‘duty to warn’: An ER doctor, shaped by war and hardship, chronicles the searing realities of Covid-19
Heavyweights By Eric Boodman As a kid, his factory work paid for his dad’s cancer care. As an oncologist, his research offers more than survival
Heavyweights By Matthew Herper In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics — and getting results
Heavyweights By Rebecca Robbins Priscilla Chan charts an ambitious, unglamorous course to fight disease. (Her husband is involved, too.)
Heavyweights By Rebecca Robbins Billionaire Sean Parker is nerding out on cancer research. Science has never seen anyone quite like him
Exclusive By Matthew Herper One of the world’s best drug hunters went after Alzheimer’s. Here’s how he lost
Heavyweights By Rick Berke Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials
Heavyweights By Andrew Joseph Elijah Cummings sparred with Martin Shkreli and Mylan’s CEO. Now he’s got a gavel to take on pharma
Heavyweights By Sharon Begley A pioneer in cancer immunotherapy sees a future where vaccines, CAR-T, and checkpoint inhibitors come together
Heavyweights By Ed Silverman and Kate Sheridan How Pfizer’s CEO flew under the political radar with price hikes — until he tangled with Trump
Heavyweights By Rob Waters Her bio reads like Silicon Valley fan fiction. At 23, she’s investing millions in the quest to defy death
Heavyweights By Andrew Joseph He takes on Eric Lander, and the scientific establishment. ‘This is who I am. I get angry.’
Heavyweights By Megan Thielking Meet Nature’s new editor: a geneticist who reads scientific papers like ‘page turners’
Heavyweights By Helen Branswell The virus hunter: In a bygone era, C.J. Peters learned how to bend the rules
Heavyweights By Andrew Joseph A veteran New York litigator is taking on opioid makers. They have a history
Heavyweights By Sharon Begley Not just for CRISPR: Lemelson-MIT Prize honors Feng Zhang for ‘big ideas that change fields’
Heavyweights By Usha Lee McFarling The creator of the pig-human chimera keeps proving other scientists wrong
Heavyweights By Meghana Keshavan Armed with science (and snark), a gynecologist takes on Trump, Goop, and all manner of bizarre health trends
First Opinion By Margaret Chan My decade leading the WHO: dirty fights and steps toward universal coverage
Heavyweights By Sharon Begley CRISPR pioneer Doudna envisions a world of woolly mammoths and unicorns
Heavyweights By Sharon Begley ‘A feature, not a bug’: George Church ascribes his visionary ideas to narcolepsy
Heavyweights By Bryan Marquard and Robert Weisman — Boston Globe Henri Termeer, biotech leader who built Genzyme into an industry giant, dies at 71